Exploring Acute Liver Damage: Slimming Health Foods and CYP3A4 Induction

被引:0
|
作者
Adachi, Makiko [1 ]
Kumagai, Takeshi [2 ]
Hosho, Keiko [3 ]
Nagata, Kiyoshi [2 ]
Fujiyoshi, Masachika [1 ]
Shimada, Miki [1 ]
机构
[1] Tottori Univ Hosp, Dept Pharm, Yonago 6838504, Japan
[2] Tohoku Med & Pharmaceut Univ, Fac Pharmaceut Sci, Lab Environm & Hlth Sci, Sendai 9818558, Japan
[3] Tottori Univ, Fac Med, Div Med & Clin Sci, Tottori 6838503, Japan
关键词
acetaminophen; Coleus forskohlii; DILI; slimming health foods; PREGNANE X RECEPTOR; CYTOCHROME-P450; ENZYMES; ACETAMINOPHEN; PARACETAMOL; HEPATOTOXICITY; MECHANISMS; METABOLITE; PREDICTION; RIFAMPICIN; HEPATITIS;
D O I
10.33160/yam.2024.05.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Patients taking multiple drugs and various health foods often develop acute hepatitis. We hypothesized that the interaction between health foods and drug metabolism was the cause of severe liver injury in these patients. Therefore, we studied changes in the activity of the drug-metabolizing enzyme, cytochrome P450 (CYP), using slimming health food extracts and elucidated the molecular mechanism of liver injury onset through hepatotoxicity evaluation. Methods For cytotoxicity testing, health food extract samples were added to HepG2 cells derived from hepatic parenchymal cells and culture medium, and cell viability was calculated 48 h after culture. To evaluate CYP3A4 induction, 3-1-10 cells constructed with a reporter linked to CYP3A4 gene were used, and reporter activity was measured 48 h after culture. Results In the chronological order of the slimming health food intake history of the patient, niacinamide and Gymnema sylvestre extracts strongly inhibited HepG2 cell viability. In contrast, dietary supplements A and Coleus forskohlii extract strongly induced CYP3A4 reporter activity. To confirm CYP3A4 induction in humans, humanized CYP3A/pregnane X receptor (PXR) mice were treated with forskolin. CYP3A4 mRNA expression levels were elevated 3.9 times compared to that of the control group ( P < 0.05). Conclusion Coleus forskohlii extract showed the strongest transcriptional activation of CYP3A4 gene. In a mouse model of human-type drug metabolism, forskolin induced CYP3A4 transcription. Thus, we concluded that CYP3A4 induction by Coleus forskohlii is one of the causes of crucial hepatocellular injury, which is a type of liver injury caused by the active metabolite of acetaminophen produced by CYP3A4.
引用
收藏
页码:124 / 134
页数:11
相关论文
共 50 条
  • [31] DNA methylation dynamics in the hepatic CYP3A4 gene promoter
    Kacevska, Marina
    Ivanov, Maxim
    Wyss, Annika
    Kasela, Silva
    Milani, Lili
    Rane, Anders
    Ingelman-Sundberg, Magnus
    BIOCHIMIE, 2012, 94 (11) : 2338 - 2344
  • [32] Investigation of Drug-Drug Interactions Caused by Human Pregnane X Receptor-Mediated Induction of CYP3A4 and CYP2C Subfamilies in Chimeric Mice with a Humanized Liver
    Hasegawa, Maki
    Tahara, Harunobu
    Inoue, Ryo
    Kakuni, Masakazu
    Tateno, Chise
    Ushiki, Junko
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (03) : 474 - 480
  • [33] Selective Mechanism-Based Inactivation of CYP3A4 by CYP3cide (PF-04981517) and Its Utility as an In Vitro Tool for Delineating the Relative Roles of CYP3A4 versus CYP3A5 in the Metabolism of Drugs
    Walsky, Robert L.
    Obach, R. Scott
    Hyland, Ruth
    Kang, Ping
    Zhou, Sue
    West, Michael
    Geoghegan, Kieran F.
    Helal, Christopher J.
    Walker, Gregory S.
    Goosen, Theunis C.
    Zientek, Michael A.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1686 - 1697
  • [34] Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates
    Filppula, A. M.
    Laitila, J.
    Neuvonen, P. J.
    Backman, J. T.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (08) : 2787 - 2798
  • [35] A comparison of 4-hydroxycholesterol:cholesterol and 6-hydroxycortisol:cortisol as markers of CYP3A4 induction
    Arrhen, Yvonne Marde
    Nylen, Hanna
    Lovgren-Sandblom, Anita
    Kanebratt, Kajsa P.
    Wide, Katarina
    Diczfalusy, Ulf
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (06) : 1536 - 1540
  • [36] Cis-acting regulatory elements regulating CYP3A4 transcription in human liver
    Collins, Joseph M.
    Wang, Danxin
    PHARMACOGENETICS AND GENOMICS, 2020, 30 (05): : 107 - 116
  • [37] CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations
    Hawkes, Colin Patrick
    Li, Dong
    Hakonarson, Hakon
    Meyers, Kevin E.
    Thummel, Kenneth E.
    Levine, Michael A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (05): : 1440 - 1446
  • [38] The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma
    Mao Qixing
    Xu Juqing
    Wang Yajing
    Dong Gaochao
    Xia Wenjie
    Shi Run
    Wang Anpeng
    Xu Lin
    Jiang Feng
    Wang Jun
    TUMOR BIOLOGY, 2017, 39 (04)
  • [39] Induction of CYP3A4 by Vinblastine: Role of the Nuclear Receptor NR1I2
    Smith, Nicola F.
    Mani, Sridhar
    Schuetz, Erin G.
    Yasuda, Kazuto
    Sissung, Tristan M.
    Bates, Susan E.
    Figg, William D.
    Sparreboom, Alex
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (11) : 1709 - 1717
  • [40] Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7
    Ueyama, Takafumi
    Tsuji, Saori
    Sugiyama, Takemi
    Tada, Masako
    SCIENTIFIC REPORTS, 2017, 7